University of Texas/Texas AM Investment Management Co (UTIMCO)’s Lexicon Pharmaceuticals LXRX Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$171K	Buy	71,427 +35,713	+100%	+$69.6K	0.02%	170
2026 Q1	$55.7K	Hold	35,714	–	–	0.01%	163
2025 Q4	$41.1K	Hold	35,714	–	–	0.01%	204
2025 Q3	$48.2K	Hold	35,714	–	–	0.01%	155
2025 Q2	$33.8K	Hold	35,714	–	–	0.01%	136
2025 Q1	$16.5K	Hold	35,714	–	–	﹤0.01%	150
2024 Q4	$26.4K	Hold	35,714	–	–	﹤0.01%	157
2024 Q3	$56.1K	Hold	35,714	–	–	0.01%	119
2024 Q2	$60K	Hold	35,714	–	–	0.01%	130
2024 Q1	$85.7K	Hold	35,714	–	–	0.02%	110
2023 Q4	$54.6K	Hold	35,714	–	–	0.02%	111
2023 Q3	$38.9K	Hold	35,714	–	–	0.02%	66
2023 Q2	$82K	Hold	35,714	–	–	0.03%	11
2023 Q1	$87K	Hold	35,714	–	–	0.03%	11
2022 Q4	$68K	Hold	35,714	–	–	0.03%	32
2022 Q3	$86K	Hold	35,714	–	–	0.03%	16
2022 Q2	$66K	Hold	35,714	–	–	0.03%	12
2022 Q1	$75K	Hold	35,714	–	–	0.04%	14
2021 Q4	$141K	Hold	35,714	–	–	0.06%	18
2021 Q3	$172K	Hold	35,714	–	–	0.1%	16
2021 Q2	$164K	Hold	35,714	–	–	0.13%	13
2021 Q1	$210K	Hold	35,714	–	–	0.12%	14
2020 Q4	$122K	Hold	35,714	–	–	0.13%	12
2020 Q3	$51K	Hold	35,714	–	–	0.05%	21
2020 Q2	$71K	Hold	35,714	–	–	0.27%	9
2020 Q1	$70K	Hold	35,714	–	–	0.1%	7
2019 Q4	$148K	Buy	+35,714	New	+$137K	0.16%	8
2019 Q2	$225K	Hold	35,714	–	–	0.28%	12
2019 Q1	$199K	Hold	35,714	–	–	0.25%	12
2018 Q4	$237K	Hold	35,714	–	–	0.26%	26
2018 Q3	$381K	Hold	35,714	–	–	0.47%	10
2018 Q2	$429K	Hold	35,714	–	–	0.17%	12
2018 Q1	$306K	Hold	35,714	–	–	0.12%	12
2017 Q4	$353K	Hold	35,714	–	–	1.36%	14
2017 Q3	$439K	Hold	35,714	–	–	1.05%	14
2017 Q2	$587K	Hold	35,714	–	–	1.74%	15
2017 Q1	$512K	Hold	35,714	–	–	1.34%	15
2016 Q4	$494K	Hold	35,714	–	–	1.42%	14
2016 Q3	$645K	Hold	35,714	–	–	1.72%	14
2016 Q2	$512K	Hold	35,714	–	–	1.49%	12
2016 Q1	$427K	Hold	35,714	–	–	1.33%	11
2015 Q4	$475K	Hold	35,714	–	–	0.98%	13
2015 Q3	$384K	Hold	35,714	–	–	0.19%	14
2015 Q2	$287K	Hold	35,714	–	–	0.1%	14
2015 Q1	$236K	Hold	35,714	–	–	0.09%	14
2014 Q4	$228K	Hold	35,714	–	–	0.59%	13
2014 Q3	$353K	Hold	35,714	–	–	1.25%	11
2014 Q2	$403K	Hold	35,714	–	–	0.15%	33
2014 Q1	$433K	Hold	35,714	–	–	0.18%	30
2013 Q4	$450K	Hold	35,714	–	–	0.32%	26
2013 Q3	$595K	Hold	35,714	–	–	0.43%	27
2013 Q2	$543K	Buy	+35,714	New	+$543K	0.39%	27

Other funds holding LXRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s LXRX Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) increased its Lexicon Pharmaceuticals (LXRX) stake by 100% in Q2 2026, buying an estimated $69.6K and bringing the position to 71,427 shares worth $171K. The position accounts for 0.02% of the portfolio, ranked #170.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in LXRX in Q2 2013 and has held it in 52 quarters since. The position peaked at $645K in Q3 2016. 79 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

University of Texas/Texas AM Investment Management Co (UTIMCO) held 71,427 shares of Lexicon Pharmaceuticals worth $171K as of Q2 2026.
University of Texas/Texas AM Investment Management Co (UTIMCO) bought 35,713 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $69.6K.
Lexicon Pharmaceuticals made up 0.02% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #170 holding.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Lexicon Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Lexicon Pharmaceuticals position peaked at $645K in Q3 2016.
79 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.